The once-daily pill offers new oral cardiovascular risk-reduction option for plan members with diabetes Heart disease is still the second leading cause of death in Canada, and most Canadians have at least one risk factor now a oncedaily GLP1 pill adds a new option for adults with type 2 diabetes and cardiovascular risk
Theyre also purchasing gut health supplements (26%)
While Coke is just tasty, energizing at most, its holier alternatives offer probiotics, adaptogens, nootropics, fiber, antioxidants, green caffeine rather than brown
Below I share my personal account of what my n=1 looks like, and an overview of what the science currently says about why GLP-1 medications may be particularly relevant for those of us with mast cell-driven, inflammatory conditions
The longest clinical trials extended to 24 weeks (approximately six months) of continuous AOD-9604 administration